Digital Flow Enhancement in Raynaud's Phenomenon With an sGC (Soluble Guanylate Cyclase) Stimulator

NCT01926847 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

23

Enrollment

INDUSTRY

Sponsor class

Conditions

Raynaud Disease

Interventions

DRUG: Riociguat (Adempas, BAY63-2521)
DRUG: Placebo

Sponsor

Bayer